Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS

Condition:   Atypical Hemolytic Uremic SyndromeIntervention:   Drug: EculizumabSponsor:   Alexion PharmaceuticalsCompleted - verified June 2014

Source: ClinicalTrials.gov - February 13, 2009 Category: Research Source Type: clinical trials